Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Angiodynamics Inc
(NQ:
ANGO
)
6.220
+0.080 (+1.30%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 13, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
279,340
Open
6.150
Bid (Size)
6.000 (1)
Ask (Size)
6.420 (1)
Prev. Close
6.140
Today's Range
6.120 - 6.257
52wk Range
5.260 - 11.38
Shares Outstanding
38,444,076
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
AngioDynamics Announces CE Mark Approval in Europe for AlphaVac F18⁸⁵ System
May 21, 2024
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics’ APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific Sessions
May 06, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Performance
YTD
-22.54%
-22.54%
1 Month
+0.81%
+0.81%
3 Month
+14.97%
+14.97%
6 Month
-17.18%
-17.18%
1 Year
-42.78%
-42.78%
More News
Read More
Insiders Buying Zumiez And 3 Other Stocks
April 09, 2024
Via
Benzinga
Medical Devices Focused AngioDynamics Unveils Upbeat 2024 Financial Outlook, Stock Soars
April 04, 2024
Via
Benzinga
Exposures
Product Safety
ANGO Stock Earnings: AngioDynamics Misses EPS, Misses Revenue for Q3 2024
April 04, 2024
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
April 04, 2024
Via
InvestorPlace
AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture
April 04, 2024
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE
April 04, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Earnings Scheduled For April 4, 2024
April 04, 2024
Via
Benzinga
AngioDynamics Resolves Decade-Long Patent Litigation With Becton, Dickinson In Settlement Agreement
April 02, 2024
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.
April 01, 2024
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024
March 19, 2024
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics to Participate in a Fireside Chat at the Oppenheimer Virtual Healthcare MedTech & Services Conference
March 06, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Hidden Gems: 7 Oversold Stocks Ready for a Major Rebound
March 04, 2024
Via
InvestorPlace
AngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Million
February 15, 2024
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics (ANGO) Stock Sinks As Market Gains: Here's Why
February 11, 2024
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
AngioDynamics Announces FDA 510(k) Clearance of Auryon XL Radial Access Catheter to Treat Peripheral Arterial Disease
January 23, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Raymond James Maintains Outperform Rating for AngioDynamics: Here's What You Need To Know
January 09, 2024
Via
Benzinga
Robinhood To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Monday
January 08, 2024
Via
Benzinga
Why AngioDynamics Stock Got Destroyed Today
January 05, 2024
Via
The Motley Fool
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 05, 2024
Via
Benzinga
ANGO Stock Earnings: AngioDynamics Beats EPS, Misses Revenue for Q2 2024
January 05, 2024
Via
InvestorPlace
Why Is Medical Devices-Focused AngioDynamics Stock Trading Lower Today?
January 05, 2024
Via
Benzinga
US Stocks Poised To Extend New Year Slump As Focus Shifts To December Jobs Data: Analyst Sees S&P Testing 4,800 On This Condition
January 05, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
AngioDynamics Reports Fiscal Year 2024 Second Quarter Financial Results; Revises Fiscal Year 2024 Guidance
January 05, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
